Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001048477-23-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-05 | 2023-10-31+ | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $0.769 | +12.0K | 40.2K | +42% | +$9,208 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | A | A | 11,840 | $0.00 | 52,014 | D | — | — | (F2) Restricted stock units granted on December 1, 2023. Price not applicable. |
| 2 | Common | Common Stock | 2023-10-31 | A | A | 133 | $69.23 | 40,174 | D | — | — | (F1) Represents the shares acquired by the reporting person on October 31, 2023, pursuant to the issuer's Employee Stock Purchase Plan. |